INSMED Inc - Common Stock, par value $0.01 per share (INSM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
INSM on Nasdaq
Shares outstanding
210,901,495
Price per share
$174.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
210,857,183
Total reported value
$30,322,142,306
% of total 13F portfolios
0.04%
Share change
+671,352
Value change
+$446,316,168
Number of holders
559
Price from insider filings
$174.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INSMED Inc - Common Stock, par value $0.01 per share (INSM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JPMORGAN CHASE & CO 11% +36% $2,827,801,936 +$964,491,533 23,014,584 +52% JPMORGAN CHASE & CO. 29 Aug 2025
Darwin Global Management, Ltd. 9.7% +13% $2,946,076,654 +$728,614,275 20,457,445 +33% Darwin Global Management, Ltd. 30 Sep 2025
VANGUARD GROUP INC 10% $1,256,380,378 18,218,973 The Vanguard Group 31 Dec 2024
BlackRock, Inc. 5.1% $979,191,070 9,729,641 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% -43% $998,278,616 -$619,088,189 6,932,009 -38% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 559 institutional investors reported holding 210,857,183 shares of INSMED Inc - Common Stock, par value $0.01 per share (INSM). This represents 100% of the company’s total 210,901,495 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JPMORGAN CHASE & CO 11% 23,047,676 +47% 0.21% $3,319,096,045
Darwin Global Management, Ltd. 9.7% 20,457,445 +5.8% 81% $2,897,797,084
VANGUARD GROUP INC 9.5% 19,935,820 +13% 0.04% $2,870,957,439
BlackRock, Inc. 5.9% 12,364,904 +11% 0.03% $1,780,669,886
FMR LLC 4.4% 9,180,963 +80% 0.07% $1,322,150,532
Capital International Investors 3.6% 7,553,853 +1% 0.18% $1,087,830,371
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% 6,931,466 -38% 0.11% $998,201,000
BAKER BROS. ADVISORS LP 3.2% 6,703,484 -13% 7% $965,368,731
D. E. Shaw & Co., Inc. 2.7% 5,657,464 +65% 0.66% $814,731,390
Artisan Partners Limited Partnership 2.3% 4,937,683 +49% 1% $711,075,729
STATE STREET CORP 1.9% 3,984,354 -6.9% 0.02% $573,786,820
GEODE CAPITAL MANAGEMENT, LLC 1.8% 3,759,427 +13% 0.03% $541,500,912
Orbis Allan Gray Ltd 1.5% 3,250,868 +113% 2% $468,157,501
RTW INVESTMENTS, LP 1.5% 3,084,558 0% 5.5% $444,207,198
AMERIPRISE FINANCIAL INC 1.3% 2,721,879 -8% 0.09% $391,978,689
Duquesne Family Office LLC 1.1% 2,423,435 +7.5% 8.9% $348,999,000
MILLENNIUM MANAGEMENT LLC 1.1% 2,336,112 +10% 0.26% $336,423,489
FRANKLIN RESOURCES INC 1% 2,139,725 -9% 0.08% $308,141,793
CITADEL ADVISORS LLC 0.98% 2,057,641 +34% 0.24% $296,320,880
Invesco Ltd. 0.95% 2,003,871 +5.7% 0.05% $288,577,400
UBS Group AG 0.78% 1,646,239 +461% 0.05% $237,074,878
BANK OF AMERICA CORP /DE/ 0.76% 1,601,806 +31% 0.02% $230,676,015
Integral Health Asset Management, LLC 0.76% 1,600,000 0% 17% $230,416,000
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 0.74% 1,555,057 -6.6% 0.58% $223,943,759
Qube Research & Technologies Ltd 0.73% 1,544,315 +43% 0.31% $222,396,803

Institutional Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 768,615 $134,457,650 +$15,300,655 $174.04 53
2025 Q3 210,857,183 $30,322,142,306 +$446,316,168 $144.01 559
2025 Q2 210,375,071 $21,148,644,502 +$1,358,877,009 $100.64 513
2025 Q1 197,789,205 $15,117,195,698 +$439,219,800 $76.29 436
2024 Q4 192,544,545 $13,293,875,240 +$244,780,319 $69.04 434
2024 Q3 188,054,494 $13,732,893,406 +$900,536,797 $73.00 411
2024 Q2 175,240,601 $11,740,766,805 +$1,771,359,793 $67.00 375
2024 Q1 149,761,616 $4,062,731,615 -$1,104,814 $27.13 284
2023 Q4 149,731,871 $4,640,473,667 +$24,712,854 $30.99 269
2023 Q3 147,357,091 $3,720,846,962 +$68,976,618 $25.25 249
2023 Q2 146,401,839 $3,087,320,690 +$30,211,671 $21.10 221
2023 Q1 145,487,988 $2,479,157,946 +$29,238,110 $17.05 229
2022 Q4 143,724,717 $2,870,747,315 +$305,150,296 $19.98 224
2022 Q3 127,521,278 $2,746,157,362 -$212,666,313 $21.54 229
2022 Q2 129,190,615 $2,547,619,834 +$40,332,207 $19.72 200
2022 Q1 126,479,239 $2,971,923,265 +$75,140,734 $23.50 211
2021 Q4 123,318,469 $3,358,792,092 -$21,477,249 $27.24 201
2021 Q3 123,374,100 $3,397,087,163 +$40,469,427 $27.54 184
2021 Q2 121,478,330 $3,456,376,124 +$431,176,988 $28.46 194
2021 Q1 106,602,088 $3,631,335,192 -$6,653,428 $34.06 194
2020 Q4 107,580,874 $3,581,395,788 -$44,371,673 $33.29 202
2020 Q3 108,714,504 $3,495,053,137 -$56,966,505 $32.14 195
2020 Q2 110,715,810 $3,045,474,894 +$374,929,259 $27.54 183
2020 Q1 97,643,990 $1,563,236,817 -$41,156,048 $16.03 159
2019 Q4 98,329,079 $2,348,053,229 -$38,855,319 $23.88 169
2019 Q3 99,035,921 $1,747,100,746 -$518,153,737 $17.64 153
2019 Q2 126,395,360 $3,235,565,096 +$1,146,114,720 $25.60 165
2019 Q1 82,194,605 $2,389,348,616 -$1,132,072 $29.07 151
2018 Q4 82,419,564 $1,081,320,258 -$9,481,669 $13.12 120
2018 Q3 80,880,640 $1,635,485,434 -$43,612,626 $20.22 120
2018 Q2 82,447,822 $1,949,876,562 +$16,668,558 $23.65 125
2018 Q1 81,818,840 $1,842,516,409 +$127,505,884 $22.52 125
2017 Q4 75,871,275 $2,365,660,554 +$39,137,828 $31.18 125
2017 Q3 73,705,883 $2,300,049,892 +$548,691,894 $31.21 142
2017 Q2 56,526,187 $969,760,710 +$39,905,047 $17.16 110
2017 Q1 56,998,661 $998,026,125 +$70,030,475 $17.51 97
2016 Q4 57,799,199 $764,693,750 +$2,353,629 $13.23 96
2016 Q3 57,474,912 $834,201,194 +$19,054,121 $14.52 93
2016 Q2 56,451,131 $556,714,141 -$8,091,952 $9.86 103
2016 Q1 57,022,278 $722,305,325 -$13,027,221 $12.67 97
2015 Q4 56,887,745 $1,032,792,029 -$19,917 $18.15 111
2015 Q3 56,767,734 $1,053,879,972 +$35,530,012 $18.57 117
2015 Q2 54,410,404 $1,328,450,938 +$21,929,946 $24.42 115
2015 Q1 53,709,876 $1,117,417,187 +$261,082,690 $20.80 117
2014 Q4 41,928,477 $648,686,215 +$11,193,962 $15.47 94
2014 Q3 41,271,273 $538,679,902 +$115,361,476 $13.05 99
2014 Q2 31,011,972 $619,318,286 +$3,350,731 $19.98 102
2014 Q1 30,157,438 $573,214,840 +$41,465,686 $19.04 108